Cargando…

Sympathetic nerve infiltration promotes stomach adenocarcinoma progression via norepinephrine/β2-adrenoceptor/YKL-40 signaling pathway

OBJECTIVE: This study aimed to address the status, role, and mechanism of sympathetic nerve infiltration in the progression of stomach adenocarcinoma (STAD). METHODS: Sympathetic nerve and its neurotransmitter NE, β-ARs, and associated signaling molecules in the STAD tissues and the adjacent tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yue-Hong, Yang, Lu-Zi, Zhou, Lan, Gao, Li-Juan, Hou, Jia-Yi, Yan, Zi, Bi, Xiao-Gang, Yan, Cai-Ping, Wang, De-Ping, Cao, Ji-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803717/ https://www.ncbi.nlm.nih.gov/pubmed/36593854 http://dx.doi.org/10.1016/j.heliyon.2022.e12468

Ejemplares similares

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Norepinephrine modulates wakefulness via α1 adrenoceptors in paraventricular thalamic nucleus
por: Wang, Yan, et al.
Publicado: (2021)

A Mechanism for Nerve Cell Excitation by Norepinephrine via Alpha-1 Adrenoceptors: Inhibition of Potassium M-Current
por: Filippov, Alexander K., et al.
Publicado: (2012)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

THE DISTRIBUTION OF LABELED NOREPINEPHRINE WITHIN SYMPATHETIC NERVE TERMINALS STUDIED WITH ELECTRON MICROSCOPE RADIOAUTOGRAPHY
por: Budd, G. C., et al.
Publicado: (1969)

Endothelin-1 and Norepinephrine Overflow from Cardiac Sympathetic Nerve Endings in Myocardial Ischemia
por: Tawa, Masashi, et al.
Publicado: (2012)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

β(3)-adrenoceptors inhibit stimulated norepinephrine release in spontaneously hypertensive rats
por: Berg, Torill
Publicado: (2014)

Sympathetic stimulation with norepinephrine may come at a cost
por: Herat, Lakshini Y., et al.
Publicado: (2019)

The different role of YKL-40 in glioblastoma is a function of MGMT promoter methylation status
por: Chen, Wei-jun, et al.
Publicado: (2020)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression
por: Wang, Bin, et al.
Publicado: (2017)

Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves’ disease
por: Chen, Yi-Ding, et al.
Publicado: (2023)

The effects of YKL-40 on angiogenic potential of HUVECs are partly mediated by syndecan-4
por: Sun, WeiJun, et al.
Publicado: (2021)

Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma
por: Zhou, Fang, et al.
Publicado: (2023)

YKL-39 is an independent prognostic factor in gastric adenocarcinoma and is associated with tumor-associated macrophage infiltration and angiogenesis
por: Xue, Ling, et al.
Publicado: (2022)

Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
por: Shcherbakova, Olga G., et al.
Publicado: (2007)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

Interactions between β-adrenergic vasodilation and cervical sympathetic nerves are mediated by α(2)-adrenoceptors in the rat masseter muscle
por: Ishii, Hisayoshi, et al.
Publicado: (2016)

A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40
por: Ngernyuang, Nipaporn, et al.
Publicado: (2017)

Correction to: Interactions between β-adrenergic vasodilation and cervical sympathetic nerves are mediated by α(2)-adrenoceptors in the rat masseter muscle
por: Ishii, Hisayoshi, et al.
Publicado: (2018)

β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced by chronic intermittent hypoxia
por: Alzahrani, Abdulaziz A., et al.
Publicado: (2020)

Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models
por: Wu, Hsueh-Fu, et al.
Publicado: (2022)

Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer
por: Kim, Steve H, et al.
Publicado: (2007)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
por: Røndbjerg, Anne K, et al.
Publicado: (2011)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2012)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis
por: Wang, Pengkun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ji2f2fan606umusp0acq3jntqv